Calla Lily Clinical Care
Drug DeliveryWebsite
Calla Lily Clinical Care valuation and funding history | Last updated: April 21, 2025 | 1 funding rounds
Current Valuation
N/A
As of April 21, 2025
Total Funding Raised
$6.9M
Across 1 round
Last Round
Early Stage VC
$2.2M
Last Funding
Apr 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| March 25, 2025 | Accelerator/Incubator | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
Calla Lily Clinical Care is currently valued at N/A as of April 21, 2025. The company has raised a total of $6.9M in funding across 1 funding round.
Explore More Data
Detailed analysis for Calla Lily Clinical Care
What is Calla Lily Clinical Care Worth in 2026?
Calla Lily Clinical Care is a leading private company in the Drug Delivery sector. Track Calla Lily Clinical Care's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Calla Lily Clinical Care Valuation is Determined
Private company valuations like Calla Lily Clinical Care's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.